Paul Glavine

Paul Glavine is the Co-Founder & Chief Growth Officer at Cybin. Paul has over 25 years of experience in the pharmaceutical and biotech industries. Prior to joining Cybin, they were the Co-Founder of Canadian Clinical Cannabinoids, a medical cannabinoids company that was acquired by Surpreme Cannabis later acquired by Canopy Growth.

Paul Glavine completed a Bachelor of Business Administration (B.B.A.) with a focus in marketing from Georgian College.

Paul Glavine reports to Doug Drysdale, CEO. They work with Allison House-Gecewicz - SVP, Clinical Operations, Eric So - President, Executive Chairman & Co-Founder, and Brett Greene - Chief Innovation Officer.